ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

462
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
29 Jan 2020 17:47

Korea - Pharma Stocks See Short Covering

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 23 January...

Logo
344 Views
Share
22 Jan 2020 11:14

How Will Mr. Market View 30% Cap Rule for Samsung Electronics & KOSPI200?

Instead of the bi-annual adjustment, the Korea Exchange is considering on changing the 30% cap rule so that the timing of the adjustment is...

Logo
487 Views
Share
22 Jan 2020 07:54

KRX Considers a 30% Cap on Samsung in March: Impact Estimation

The local news outlets report that the KRX is considering applying the 30% cap on Samsung Electronics as early as March, possibly right after the...

Logo
467 Views
Share
21 Jan 2020 17:51

Korea - Celltrion Shorts Increase, Semco Covering Continues

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 17 January 2020....

Logo
389 Views
Share
bullishCelltrion Inc
16 Jan 2020 14:25

Celltrion Merger: Is It for Real This Time? Why Next Year?

Almost every year, we hear this same old story about the Celltrion merger when we approach the OGM season in March. It has always been Chairman Seo...

Logo
452 Views
Share
x